References
- Torrance G, Markham B, Feeny D, Rosenbloom D, Gafni A. Risk-benefit and Quality of Life analyses of prescription drugs. Health and Welfare Canada., Ottawa 1990
- Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of Life measures in health care. I: Applications and issues in assessment. Br Med J 1992; 305: 1074–7
- Farmer R, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818–25
- Mallett S J, Lennart-Jones J E, Bingley J, Gilon E. Living with disease. Colitis. Lancet 1978; 2: 619–21
- Meyers S, Walfish J S, Sachar D B, Greenstein A J, Hill A G, Janowitz HD. Quality of Life after surgery for Crohn's disease: a psychological survey. Gastroenterology 1980; 78: 1–6
- Torrance G W, Thomas W H, Sackett D LS. A utility maximization model for evaluation of health care programs. Health Res 1972; 7: 118–33
- Bergner M, Bobbitt R A, Carter W B, Bilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care 1981; 19: 787–805
- Ware J E, Brook R H, Davies-Avery A, et al. Conceptualization and measurement of health for adults in the health insurance study. Model of Health and Methodology, Vol. 1. Rand Corporation. Santa Monica, California 1980
- Drossman D A, Patrick D L, Mitchell C M, Murp E A, Zagomi E A, Appelbaum MI. HRQOL in inflammatory bowel disease: functional status and patient worries and concerns. Dig Dis Sci 1989; 34: 1379–86
- Farmer R G, Easley K A, Farmer JM. Quality of Life assessment by patients with inflammatory bowel disease. Clece Clin J Med 1992; 59: 35–52
- Mitchell A, Guyatt G, Singer J, Irvine E J, Goodacre R, Tompkins C, et al. Quality of Life in patients with inflammatory bowel disease. J Clin Gastroenterol 1988; 10: 306–10
- McLeod R S, Churchill D N, Lock A M, Vanderburgh S, Cohen Z. Quality of Life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991; 101: 1307–13
- McCarthy DM. Quality of Life: a critical assessment. Scand J Gastroenterol 1995; 30: 141–6, Suppl 208
- Guyatt G H, Mitchell A, Irvine E J, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804–10
- Love J R, Irvine E J, Fedorak RN. Quality of Life in inflammatory bowel disease. J Clin Gastroenterol 1992; 14: 15–9
- Irvine E J, Feagan B, Rochon J, Archambault A, Fedorak R N, Groll A, et al. Quality of Life; a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology 1994; 106: 287–96
- Feagan B G, McDonald J WD, Rochon J, Laupacis A, Fedorak R N, Kinnear D, et al. Low-dose cyclosporine for the treatment of Crohn's disease. New Engl J Med 1994; 330: 1846–51
- Martin F, Sutherland L, Beck I T, et al. Oral 5-ASA versus prednisone in short term treatment of Crohn's disease: a multicentre controlled trial. Can J Gastroenterol 1990; 4: 452–7
- The Canadian inflammatory bowel disease study group. Oral budesonide in active Crohn's disease: results of a randomized placebo controlled, double-blind, multicenter trial. Gastroenterology 1993; 104: A675
- The Canadian inflammatory bowel disease study group. Budesonide 9 or 15 mg rapidly improves Quality of Life in active Crohn's disease. Gut 1993; 34: S53